Company · CIK 0001907108 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Lexeo Therapeutics, Inc. · LXEO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 SForm 4 → | Aug 19, 5:00 pm EDT | Louis Edward TamayoChief Financial Officer | 4,117 | $4.91 | $20,203 | 92,907 | −4.24% | |
| Aug 18, 2026 SForm 4 → | Aug 19, 5:00 pm EDT | Richard Nolan TownsendChief Executive Officer, Director | 3,345 | $4.95 | $16,562 | 374,472 | −0.89% | |
| Aug 18, 2026 SForm 4 → | Aug 19, 5:00 pm EDT | Jose Manuel OteroChief Operating Officer | 1,304 | $4.96 | $6,464 | 136,178 | −0.95% | |
| Jul 1, 2026 SForm 4 → | Jul 1, 6:49 pm EDT | Louis Edward TamayoChief Financial Officer | 4,641 | $4.49 | $20,838 | 97,024 | −4.56% | |
| Jul 1, 2026 SForm 4 → | Jul 1, 6:49 pm EDT | Jose Manuel OteroChief Operating Officer | 4,666 | $4.48 | $20,904 | 137,482 | −3.28% | |
| Jul 1, 2026 SForm 4 → | Jul 1, 6:48 pm EDT | Narinder Pal BhallaChief Medical Officer | 22,306 | $4.42 | $98,593 | 82,194 | −21.3% | |
| Jul 1, 2026 SForm 4 → | Jul 1, 6:47 pm EDT | Richard Nolan TownsendChief Executive Officer, Director | 25,947 | $4.48 | $116,243 | 377,817 | −6.43% | |
| Jun 29, 2026 AForm 4 → | Jul 1, 6:49 pm EDT | Louis Edward TamayoChief Financial Officer | 12,000 | — | — | 101,665 | — | |
| Jun 29, 2026 AForm 4 → | Jul 1, 6:49 pm EDT | Jose Manuel OteroChief Operating Officer | 12,060 | — | — | 142,148 | — | |
| Jun 29, 2026 AForm 4 → | Jul 1, 6:48 pm EDT | Narinder Pal BhallaChief Medical Officer | 55,000 | — | — | 104,500 | — | |
| Jun 29, 2026 AForm 4 → | Jul 1, 6:47 pm EDT | Richard Nolan TownsendChief Executive Officer, Director | 67,000 | — | — | 403,764 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 AForm 4 → | Jun 29, 4:45 pm EDT | Steven AltschulerDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:45 pm EDT | Mette Kirstine AggerDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:44 pm EDT | Brenda CooperstoneDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:43 pm EDT | Reinaldo M DiazDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:42 pm EDT | Tolga TangulerDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:41 pm EDT | Timothy Van HauwermeirenDirector | 35,000 | — | — | 35,000 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:40 pm EDT | Paula H CholmondeleyDirector | 35,000 | — | — | 35,000 | — |